Eisai completes solid dose plant in Suzhou, China by Eric Palmer Thursday, January 11, 2018 With plans for further expansion in China, Japan’s Eisai has opened a new solid dose plant in Suzhou.
Eisai tracker keeps tabs on out-and-about dementia patients by Beth Snyder Bulik Wednesday, November 29, 2017 Seniors and dementia patients in Japan can go out more safely thanks to a new tracking tool from Eisai.
Eisai 'bewildered' by German cost watchdog's Halaven assessment by Eric Sagonowsky Tuesday, September 6, 2016 After suffering key patent losses, Eisai's new cancer meds are critical to its rebound. But for the second time this summer, the Japanese drugmaker has hit a hurdle with Europe's cost watchdogs.